Biotech | August 05, 2021
Novavax signs agreement with European Commission for COVID19 vaccine
Deal for 100 million doses with additional 100 million through 2023
Deal for 100 million doses with additional 100 million through 2023
Innovative solutions and a deep understanding of the market makes this a unique combination
It had an estimated market size of US $ 32 million as of June 2021
Total income grew in the quarter
EPS climbs to Rs 9.25 for the quarter
Reinforcing position as a premier provider of end-to-end research intelligence solutions for Life Sciences
AstraZeneca, Sinopharm and Moderna were part of the study
It is part of the company’s pain/analgesics portfolio of OTC products
Ibuprofen and Famotidine tablets approved by FDA
Arrow is the marketing partner in US
Subscribe To Our Newsletter & Stay Updated
